{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:24:21Z","timestamp":1794306261364,"version":"4.9.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/md.0000000000004807","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T12:53:32Z","timestamp":1473252812000},"page":"e4807","source":"Crossref","is-referenced-by-count":12,"title":["Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition"],"prefix":"10.1097","volume":"95","author":[{"given":"St\u00e9phane","family":"Mathis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Franques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Vallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-65-20210226","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11910-011-0237-4","article-title":"An update on monoclonal gammopathy and neuropathy","volume":"12","author":"Ramchandren","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R2-65-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0889-8588(18)30348-4","article-title":"Diagnostic criteria of multiple myeloma","volume":"6","author":"Kyle","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"R3-65-20210226","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-65-20210226","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"R5-65-20210226","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1158\/1078-0432.CCR-08-3150","article-title":"Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R6-65-20210226","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","article-title":"European Federation of Neurological SocietiesPeripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Societyfirst revision.","volume":"15","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"R7-65-20210226","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0b013e3181b59a80","article-title":"Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy","volume":"73","author":"Kuijf","year":"2009","journal-title":"Neurology"},{"key":"R8-65-20210226","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0022-510X(95)00343-Z","article-title":"Link between peripheral neuropathy and monoclonal dysglobulinemia: a study of 66 cases","volume":"137","author":"Vallat","year":"1996","journal-title":"J Neurol Sci"},{"key":"R9-65-20210226","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1529-8027.2002.02013.x","article-title":"LR white post-embedding colloidal gold method to immunostain MBP, P0, NF and S100 in glutaraldehyde fixed peripheral nerve tissue","volume":"7","author":"Keita","year":"2002","journal-title":"J Peripher Nerv Syst"},{"key":"R10-65-20210226","first-page":"979","article-title":"Neuropathies associated with IgG and IgA monoclonal gammopathy","volume":"158","author":"Nobile-Orazio","year":"2002","journal-title":"Rev Neurol (Paris"},{"key":"R11-65-20210226","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/brain\/118.2.359","article-title":"Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy","volume":"118","author":"Simmons","year":"1995","journal-title":"Brain"},{"key":"R12-65-20210226","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1468-1331.2003.00687.x","article-title":"Polyneuropathy associated with IgG\/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases","volume":"10","author":"Magy","year":"2003","journal-title":"Eur J Neurol"},{"key":"R13-65-20210226","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1531-8249(200006)47:6<808::AID-ANA15>3.0.CO;2-8","article-title":"Myelin widenings and MGUS-IgA: an immunoelectron microscopic study","volume":"47","author":"Vallat","year":"2000","journal-title":"Ann Neurol"},{"key":"R14-65-20210226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.micron.2006.12.005","article-title":"Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia","volume":"39","author":"Vallat","year":"2008","journal-title":"Micron"},{"key":"R15-65-20210226","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnen\/64.5.386","article-title":"IgG neuropathy: an immunoelectron microscopic study","volume":"64","author":"Vallat","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"R16-65-20210226","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"N Engl J Med"},{"key":"R17-65-20210226","first-page":"CD005376","article-title":"Treatment for IgG and IgA paraproteinaemic neuropathy","volume":"3","author":"Stork","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-65-20210226","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1097\/MD.0000000000000394","article-title":"Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case series","volume":"94","author":"Duchesne","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R19-65-20210226","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/10428190109099321","article-title":"Malignant transformation of monoclonal gammopathy of undetermined significance: cumulative incidence and prognostic factors","volume":"42","author":"Van De Donk","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R20-65-20210226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2141.2011.08573.x","article-title":"Guidelines for the diagnosis and management of multiple myeloma 2011","volume":"154","author":"Bird","year":"2011","journal-title":"Br J Haematol"},{"key":"R21-65-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/imt.15.107","article-title":"Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy","volume":"8","author":"Mathis","year":"2016","journal-title":"Immunotherapy"},{"key":"R22-65-20210226","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/jnnp.2009.177576","article-title":"Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy","volume":"81","author":"Bedi","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R23-65-20210226","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1158\/1535-7163.MCT-05-0340","article-title":"IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells","volume":"5","author":"Takebe","year":"2006","journal-title":"Mol Cancer Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:33:08Z","timestamp":1620959588000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201609060-00065"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":23,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004807","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}